XML 35 R16.htm IDEA: XBRL DOCUMENT
v3.25.1

Other Current Assets | 12 Months Ended
--- | ---
Dec. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] |
Other Current Assets | 6. Other Current Assets Other current assets consisted of the following at December 31: Schedule of Other Current Assets
|  | 2024 |  |  | 2023 |
Current: |  |  |  |  |  |  |  |
Prepaid clinical trial costs |  | $ | 6,768,668 |  |  | $ | 8,763,150 |
Miscellaneous receivable |  |  | 1,600,621 |  |  |  | 805,882 |
Directors & officers’ insurance |  |  | 256,629 |  |  |  | 157,453 |
Other |  |  | 841,329 |  |  |  | 281,364 |
Total |  | $ | 9,467,247 |  |  | $ | 10,007,849 |

X
- References No definition available. + Details
Name: | us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for other current assets. + References No definition available. + Details
Name: | us-gaap_OtherCurrentAssetsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration